세계의 줄기세포 치료 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.

Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.

The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson's disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).

This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stem Cell Therapy by region & country, by Type, and by Application.

The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.

Market Segmentation

By Company

• Medipost
• Theracell Advanced Biotechnology
• Nature Cell
• Stempeutics
• Regeneus
• Bluebird bio, Inc
• NIPRO
• Kyowa Kirin
• CorestemChemon Inc.
• ANTEROGEN.CO., LTD.
• Holostem
• NuVasive
• JCR Pharmaceutical
• Pharmicell
• Medi-post
• Anterogen
• Takeda (TiGenix)

Segment by Type

• Allogeneic Stem Cell Therapies
• Autologous Stem Cell Therapies

Segment by Application

• Neurodegenerative Diseases
• Cardiovascular Disorders
• Autoimmune Conditions
• Orthopedic Injuries
• Cancer
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Stem Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Stem Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Stem Cell Therapy Product Introduction
• 1.2 Global Stem Cell Therapy Market Size Forecast (2020-2031)
• 1.3 Stem Cell Therapy Market Trends & Drivers
  • 1.3.1 Stem Cell Therapy Industry Trends
  • 1.3.2 Stem Cell Therapy Market Drivers & Opportunity
  • 1.3.3 Stem Cell Therapy Market Challenges
  • 1.3.4 Stem Cell Therapy Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Stem Cell Therapy Players Revenue Ranking (2024)
• 2.2 Global Stem Cell Therapy Revenue by Company (2020-2025)
• 2.3 Key Companies Stem Cell Therapy Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Stem Cell Therapy Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Stem Cell Therapy
• 2.6 Stem Cell Therapy Market Competitive Analysis
  • 2.6.1 Stem Cell Therapy Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Stem Cell Therapy Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Allogeneic Stem Cell Therapies
  • 3.1.2 Autologous Stem Cell Therapies
• 3.2 Global Stem Cell Therapy Sales Value by Type
  • 3.2.1 Global Stem Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Stem Cell Therapy Sales Value, by Type (2020-2031)
  • 3.2.3 Global Stem Cell Therapy Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Neurodegenerative Diseases
  • 4.1.2 Cardiovascular Disorders
  • 4.1.3 Autoimmune Conditions
  • 4.1.4 Orthopedic Injuries
  • 4.1.5 Cancer
  • 4.1.6 Others
• 4.2 Global Stem Cell Therapy Sales Value by Application
  • 4.2.1 Global Stem Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Stem Cell Therapy Sales Value, by Application (2020-2031)
  • 4.2.3 Global Stem Cell Therapy Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Stem Cell Therapy Sales Value by Region
  • 5.1.1 Global Stem Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Stem Cell Therapy Sales Value by Region (2020-2025)
  • 5.1.3 Global Stem Cell Therapy Sales Value by Region (2026-2031)
  • 5.1.4 Global Stem Cell Therapy Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Stem Cell Therapy Sales Value, 2020-2031
  • 5.2.2 North America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Stem Cell Therapy Sales Value, 2020-2031
  • 5.3.2 Europe Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Stem Cell Therapy Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Stem Cell Therapy Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Stem Cell Therapy Sales Value, 2020-2031
  • 5.5.2 South America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Stem Cell Therapy Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Stem Cell Therapy Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Stem Cell Therapy Sales Value, 2020-2031
  • 6.3.2 United States Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Stem Cell Therapy Sales Value, 2020-2031
  • 6.4.2 Europe Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Stem Cell Therapy Sales Value, 2020-2031
  • 6.5.2 China Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Stem Cell Therapy Sales Value, 2020-2031
  • 6.6.2 Japan Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Stem Cell Therapy Sales Value, 2020-2031
  • 6.7.2 South Korea Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Stem Cell Therapy Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Stem Cell Therapy Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Stem Cell Therapy Sales Value, 2020-2031
  • 6.9.2 India Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Stem Cell Therapy Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Medipost
  • 7.1.1 Medipost Profile
  • 7.1.2 Medipost Main Business
  • 7.1.3 Medipost Stem Cell Therapy Products, Services and Solutions
  • 7.1.4 Medipost Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Medipost Recent Developments
• 7.2 Theracell Advanced Biotechnology
  • 7.2.1 Theracell Advanced Biotechnology Profile
  • 7.2.2 Theracell Advanced Biotechnology Main Business
  • 7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Products, Services and Solutions
  • 7.2.4 Theracell Advanced Biotechnology Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Theracell Advanced Biotechnology Recent Developments
• 7.3 Nature Cell
  • 7.3.1 Nature Cell Profile
  • 7.3.2 Nature Cell Main Business
  • 7.3.3 Nature Cell Stem Cell Therapy Products, Services and Solutions
  • 7.3.4 Nature Cell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Nature Cell Recent Developments
• 7.4 Stempeutics
  • 7.4.1 Stempeutics Profile
  • 7.4.2 Stempeutics Main Business
  • 7.4.3 Stempeutics Stem Cell Therapy Products, Services and Solutions
  • 7.4.4 Stempeutics Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Stempeutics Recent Developments
• 7.5 Regeneus
  • 7.5.1 Regeneus Profile
  • 7.5.2 Regeneus Main Business
  • 7.5.3 Regeneus Stem Cell Therapy Products, Services and Solutions
  • 7.5.4 Regeneus Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Regeneus Recent Developments
• 7.6 Bluebird bio, Inc
  • 7.6.1 Bluebird bio, Inc Profile
  • 7.6.2 Bluebird bio, Inc Main Business
  • 7.6.3 Bluebird bio, Inc Stem Cell Therapy Products, Services and Solutions
  • 7.6.4 Bluebird bio, Inc Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Bluebird bio, Inc Recent Developments
• 7.7 NIPRO
  • 7.7.1 NIPRO Profile
  • 7.7.2 NIPRO Main Business
  • 7.7.3 NIPRO Stem Cell Therapy Products, Services and Solutions
  • 7.7.4 NIPRO Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.7.5 NIPRO Recent Developments
• 7.8 Kyowa Kirin
  • 7.8.1 Kyowa Kirin Profile
  • 7.8.2 Kyowa Kirin Main Business
  • 7.8.3 Kyowa Kirin Stem Cell Therapy Products, Services and Solutions
  • 7.8.4 Kyowa Kirin Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Kyowa Kirin Recent Developments
• 7.9 CorestemChemon Inc.
  • 7.9.1 CorestemChemon Inc. Profile
  • 7.9.2 CorestemChemon Inc. Main Business
  • 7.9.3 CorestemChemon Inc. Stem Cell Therapy Products, Services and Solutions
  • 7.9.4 CorestemChemon Inc. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.9.5 CorestemChemon Inc. Recent Developments
• 7.10 ANTEROGEN.CO., LTD.
  • 7.10.1 ANTEROGEN.CO., LTD. Profile
  • 7.10.2 ANTEROGEN.CO., LTD. Main Business
  • 7.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services and Solutions
  • 7.10.4 ANTEROGEN.CO., LTD. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.10.5 ANTEROGEN.CO., LTD. Recent Developments
• 7.11 Holostem
  • 7.11.1 Holostem Profile
  • 7.11.2 Holostem Main Business
  • 7.11.3 Holostem Stem Cell Therapy Products, Services and Solutions
  • 7.11.4 Holostem Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Holostem Recent Developments
• 7.12 NuVasive
  • 7.12.1 NuVasive Profile
  • 7.12.2 NuVasive Main Business
  • 7.12.3 NuVasive Stem Cell Therapy Products, Services and Solutions
  • 7.12.4 NuVasive Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.12.5 NuVasive Recent Developments
• 7.13 JCR Pharmaceutical
  • 7.13.1 JCR Pharmaceutical Profile
  • 7.13.2 JCR Pharmaceutical Main Business
  • 7.13.3 JCR Pharmaceutical Stem Cell Therapy Products, Services and Solutions
  • 7.13.4 JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.13.5 JCR Pharmaceutical Recent Developments
• 7.14 Pharmicell
  • 7.14.1 Pharmicell Profile
  • 7.14.2 Pharmicell Main Business
  • 7.14.3 Pharmicell Stem Cell Therapy Products, Services and Solutions
  • 7.14.4 Pharmicell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.14.5 Pharmicell Recent Developments
• 7.15 Medi-post
  • 7.15.1 Medi-post Profile
  • 7.15.2 Medi-post Main Business
  • 7.15.3 Medi-post Stem Cell Therapy Products, Services and Solutions
  • 7.15.4 Medi-post Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.15.5 Medi-post Recent Developments
• 7.16 Anterogen
  • 7.16.1 Anterogen Profile
  • 7.16.2 Anterogen Main Business
  • 7.16.3 Anterogen Stem Cell Therapy Products, Services and Solutions
  • 7.16.4 Anterogen Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.16.5 Anterogen Recent Developments
• 7.17 Takeda (TiGenix)
  • 7.17.1 Takeda (TiGenix) Profile
  • 7.17.2 Takeda (TiGenix) Main Business
  • 7.17.3 Takeda (TiGenix) Stem Cell Therapy Products, Services and Solutions
  • 7.17.4 Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
  • 7.17.5 Takeda (TiGenix) Recent Developments

8 Industry Chain Analysis

• 8.1 Stem Cell Therapy Industrial Chain
• 8.2 Stem Cell Therapy Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Stem Cell Therapy Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Stem Cell Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer